Yes, fully agree. Covid has seen the acceptance of telehelath and rapid diagnostic tests. It's probably progressed AT1 core business function by several years. Even if management has seemed to have missed capturing big supply contracts, on face value. But I still think well be seeing huge revenue figures this quarter on the POC test sales.
Yes, fully agree. Covid has seen the acceptance of telehelath...
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $17.25M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.6¢ | $21.85K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 390952 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 378124 | 6 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |